MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses.

Nabil NoureddinVeeral H AjmeraJaclyn BergstromRichele BettencourtDaniel Q HuangHarris SiddiqiAbdul M MajzoubTarek NayfehNobuharu TamakiNamiki IzumiHirokazu TakahashiRamzan IdilmanMesut GumussoyDigdem Kuru OzAyse ErdenStephen Caldwell

Published in: Alimentary pharmacology & therapeutics (2023)

A combination of MRI-based biomarker and blood tests, MEFIB-Index and MAST-Score can predict the risk of hepatic decompensation in patients with MASLD.

Keyphrases

meta analyses
systematic review
magnetic resonance imaging
insulin resistance
contrast enhanced
randomized controlled trial
electronic health record
high fat diet
oxidative stress
big data
skeletal muscle
deep learning